뒤로
BioInvent International AB (publ) (BOVNF) 재무
BOVNF 주가 차트
BOVNF 재무
BioInvent International AB (publ)
$3.28
0%
$0
종가: Mar 24, 16:00:00 GMT-4
$3.28
0%
$0
프리마켓: Mar 25, 06:22:01 GMT-4
주요 통계
이전 종가
$3.28
시가
$4.7
일일 범위
$3.28 - $4.7
52주 범위
$3.28 - $4.7
거래량
908
평균 거래량
0
배당수익률
--
EPS(TTM)
-0.47
시가총액
$216.4M
BIOINVENT INTERNATIONAL AB란 무엇인가요?
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. The company is headquartered in Lund, Skane and currently employs 109 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.